PRPO logo.png
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
October 16, 2018 07:47 ET | Precipio, Inc.
Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
PRPO logo.png
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
August 22, 2018 21:45 ET | Precipio, Inc.
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), wishes to remind...
PRPO logo.png
Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
August 17, 2018 07:37 ET | Precipio, Inc.
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....
PRPO logo.png
Precipio Appoints New Board Member to Replace Departing Director
August 09, 2018 07:37 ET | Precipio, Inc.
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
PRPO logo.png
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
June 19, 2018 07:38 ET | Precipio, Inc.
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
PRPO logo.png
Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer
May 17, 2018 07:38 ET | Precipio, Inc.
Ultra-sensitive enrichment kit enables development of low cost detection tests, allowing optimized patient treatment NEW HAVEN, Conn., May 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
PRPO logo.png
Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology
April 03, 2018 07:38 ET | Precipio, Inc.
NEW HAVEN, Conn., April 03, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that, in response to recent articles, its approach using ICE...
PRPO logo.png
Precipio Restructures Capitalization Table
March 22, 2018 07:37 ET | Precipio, Inc.
NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), in an 8-K issued today announced an agreement with investors in certain 2017...
PRPO logo.png
Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform
March 20, 2018 07:37 ET | Precipio, Inc.
NEW HAVEN, Conn., March 20, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has successfully incorporated the use of High Resolution Melt...
PRPO logo.png
Precipio Settles Lawsuit with Crede Capital
March 13, 2018 08:38 ET | Precipio, Inc.
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has settled its lawsuit with Crede Capital Group LLC,...